Hemodialysis and Peritoneal Dialysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Hemodialysis and Peritoneal Dialysis Market is projected to grow from USD 80.12 Billion in 2025 to USD 119.91 Billion by 2031, registering a CAGR of 6.95%. While hemodialysis functions by using an external machine to filter blood, peritoneal dialysis utilizes the peritoneum within the abdomen as an internal natural filter. The market is primarily propelled by the increasing prevalence of end-stage renal disease, which is closely linked to the aging global population and the rising incidence of lifestyle-dependent conditions such as diabetes and hypertension. These factors create a fundamental need for life-sustaining renal replacement therapies, ensuring demand remains robust regardless of technological shifts. According to the International Society of Nephrology, approximately 850 million individuals globally were estimated to be affected by chronic kidney disease in 2023, underscoring the massive health burden supporting this sector.

Despite this strong demand, a significant challenge impeding market expansion is the acute shortage of skilled healthcare professionals, including nephrologists and specialized dialysis nurses, required to administer these complex treatments. This workforce scarcity restricts the operational capacity of dialysis centers and limits patient access to care, particularly in developing regions where infrastructure is already strained. Furthermore, the high recurring costs associated with long-term therapy and inconsistent reimbursement policies across different jurisdictions create substantial economic barriers that hinder the broader accessibility and growth of dialysis services.

Market Drivers

The escalating global prevalence of chronic kidney disease and end-stage renal disease serves as the primary catalyst for market expansion, fundamentally driven by the rising incidence of diabetes and hypertension. As these lifestyle-dependent conditions accelerate the progression of renal failure, they create an unavoidable and sustained demand for life-sustaining therapies, particularly among the aging geriatric population. This demographic shift necessitates robust operational capacities within dialysis networks to manage increasing patient volumes. Illustrating the scale of this need, DaVita Inc. reported in its '4th Quarter 2023 Results' that it provided dialysis services to approximately 250,200 patients across its network by the end of 2023, highlighting the vast population requiring daily or weekly life-support treatments.

Concurrently, the market is being reshaped by a growing adoption of cost-effective home-based dialysis modalities. Healthcare systems and insurance providers are increasingly incentivizing home dialysis to alleviate the financial burden of traditional in-center treatments, while patients favor the modality for its convenience and improved quality of life.

Technological advancements in portable devices have further facilitated this transition, enabling broader patient uptake. According to Fresenius Medical Care's 'Non-financial Group Report 2023', the number of their patients receiving home dialysis worldwide reached 31,258 as of December 31, 2023. This shift is supported by substantial investment; Baxter International reported that sales from continuing operations in the U.S. alone totaled $7.00 billion for the full year 2023, reflecting significant capital flow into the renal care market.

Market Challenges

The acute shortage of skilled healthcare professionals represents a critical bottleneck restricting the expansion of the global hemodialysis and peritoneal dialysis market. While demand for renal replacement therapies continues to rise due to demographic shifts, the operational capacity of dialysis centers is frequently capped by the unavailability of qualified staff rather than a lack of equipment. This workforce deficit directly impedes the establishment of new facilities and reduces patient turnover in existing clinics, effectively stalling revenue generation in high-demand areas. Consequently, manufacturers and service providers face a ceiling on growth as the adoption of their technologies depends heavily on the availability of trained personnel to administer care.

According to the International Society of Nephrology, in 2024, approximately 64% of surveyed countries reported a shortage of nephrologists, while 58% reported a deficit in dialysis nurses. This scarcity is particularly detrimental in emerging economies where the gap between patient volume and available clinical expertise is widest. By limiting the delivery of essential treatments, this human resource crisis prevents the market from fully capitalizing on the escalating prevalence of chronic kidney disease, thereby dampening overall industry momentum.

Market Trends

The emergence of sustainable and green dialysis technologies is rapidly becoming a critical trend as the industry seeks to mitigate the high environmental footprint associated with traditional renal care. Conventional hemodialysis processes are resource-intensive, consuming vast quantities of water and electricity, which drives manufacturers and service providers to engineer eco-friendly systems capable of minimizing waste without compromising clinical quality. This shift is characterized by the implementation of water conservation protocols and energy-efficient infrastructure to align with global environmental, social, and governance (ESG) standards. According to DaVita Inc.'s '2024 Community Care' report, the company saved more than 75 million gallons of water through efficiency projects in 2024, illustrating the tangible impact of these sustainability initiatives.

Simultaneously, the development of wearable and portable dialysis devices is fundamentally altering the technological framework of renal replacement therapy by decoupling treatment from heavy, stationary infrastructure. Unlike the general shift toward home care driven by reimbursement models, this trend focuses specifically on engineering innovations that allow for compact, all-in-one consoles to offer hospital-grade efficacy in mobile formats. These advancements are gaining traction not only for their patient-centric design but also for their versatility in acute and sub-acute clinical settings where space and mobility are premium assets. According to Outset Medical, Inc.'s 'Fourth Quarter and Full Year 2024 Financial Results', the installed base for its Tablo console reached nearly 6,000 units, representing a 10 percent growth in 2024, signaling a robust market appetite for these next-generation platforms.

Key Players Profiled in the Hemodialysis and Peritoneal Dialysis Market

• Baxter International Inc.
• B. Braun Melsungen AG
• Fresenius Medical Care AG
• Medtronic, Inc.
• Asahi Kasei Medical Co., Ltd.
• Nipro Corp
• DaVita Inc.
• Becton Dickinson & Co
• Nikkiso Co., Ltd.

Report Scope

In this report, the Global Hemodialysis and Peritoneal Dialysis Market has been segmented into the following categories:

Hemodialysis and Peritoneal Dialysis Market, by Type:

• Hemodialysis
• Peritoneal Dialysis

Hemodialysis and Peritoneal Dialysis Market, by Product:

• Devices
• Consumables
• Services

Hemodialysis and Peritoneal Dialysis Market, by End user:

• Home-based
• Hospital-based

Hemodialysis and Peritoneal Dialysis Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodialysis and Peritoneal Dialysis Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.